A phase II study of CLAG regimen in combination with imatinib mesylate (Gleevec) in refractory or relapsed Acute Myeloid leukemia.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Imatinib (Primary) ; Cladribine; Cytarabine; Filgrastim
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 17 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Apr 2014 Planned End Date changed from 1 May 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.